• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 19, 2009

View Archived Issues

Johnson & Johnson reports third quarter 2009 results

Read More

BIBW-2948 not well tolerated in 4-week chronic obstructive pulmonary disease study

Read More

ADC-4022 given with budesonide protects lung function in COPD patients

Read More

Alimera Sciences completes 2-year patient follow-up for phase III Iluvien trial in DME

Read More

Provectus expands compassionate use program of PV-10 to cancer patients in U.S.

Read More

Pfizer completes acquisition of Wyeth

Read More

ZyStor Therapeutics cleared by FDA to start phase I trial of ZC-701 in Pompe disease

Read More

FDA recommends approval of Acorda Therapeutics' Fampridine-SR for MS

Read More

CSC and FSMA complete pre-IND meeting with FDA for stem cell-derived therapy for SMA

Read More

Moxaverine increases ocular blood flow in macular degeneration, glaucoma patients

Read More

Medarex releases full phase II results with MDX-100 in rheumatoid arthritis

Read More

Selective glucocorticoid receptor modulator has less effect on bone biomarkers

Read More

Anti-Fas IgM monoclonal antibody ARG-098 decreases rheumatoid arthritis activity

Read More

A-940894 shows potent in vivo/in vitro anti-inflammatory activity

Read More

CB1 receptor antagonists reported by sanofi-aventis for the treatment of diabetes

Read More

Cancer Research Technology claims Chk1 inhibitors for the treatment of cancer

Read More

Novel anti-tuberculosis compounds described by French scientists

Read More

FDA approves Merck & Co.'s Gardasil for prevention of genital warts in males

Read More

Cenomed BioSciences presents anti-emetic candidate devoid of anxiogenic effects

Read More

Immunomedics reports results for UCB's new SLE candidate, epratuzumab

Read More

Ono obtains approval in Japan for anti-emetic drug, Emend

Read More

NexMed provides update on antifungal agent NM-100060

Read More

Cervarix approval in Japan for prevention of cervical cancer caused by HPV

Read More

Soligenix initiates confirmatory phase III orBec trial in acute gastrointestinal GVHD

Read More

Prograf approved in Japan for the additional indication of myasthenia gravis

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe